Journal of Leukemia
Open Access

Department of Hematology and Oncology, Harvard Medical School, Boston, USA

Publications

• Perspective   
  The Role of Minimal Residual Disease Monitoring in Optimizing Targeted Therapy Outcomes
  Author(s): John Greg*
  
  DOI: 10.35248/2329-6917-25.13.456

  HTML PDF